TreeWAS – Variant ID: rs4453858

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D25.0 Submucous leiomyoma of uterus	0.000	0.960	0.040
D05.9 Carcinoma in situ of breast, unspecified	0.027	0.973	0.000
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.026	0.974	0.000
K51.9 Ulcerative colitis, unspecified	0.000	0.975	0.025
D05 Carcinoma in situ of breast	0.021	0.979	0.000
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.021	0.979	0.000
K62.8 Other specified diseases of anus and rectum	0.000	0.979	0.021
K51 Ulcerative colitis	0.000	0.980	0.020
I44.7 Left bundle-branch block, unspecified	0.000	0.981	0.019
D05.7 Other carcinoma in situ of breast	0.019	0.981	0.000
D05.1 Intraductal carcinoma in situ	0.019	0.981	0.000
N94.3 Premenstrual tension syndrome	0.018	0.982	0.000
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.018	0.982	0.000
N94.2 Vaginismus	0.018	0.982	0.000
K51.8 Other ulcerative colitis	0.000	0.983	0.017
K51.4 Pseudopolyposis of colon	0.000	0.983	0.017
N94.0 Mittelschmerz	0.016	0.984	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.984	0.016
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.984	0.016
N94.5 Secondary dysmenorrhoea	0.015	0.984	0.000
N94.1 Dyspareunia	0.015	0.985	0.000
D05.0 Lobular carcinoma in situ	0.015	0.985	0.000
N94.4 Primary dysmenorrhoea	0.015	0.985	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.986	0.014
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.988	0.012
D25 Leiomyoma of uterus	0.000	0.988	0.012
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.988	0.011
D25.1 Intramural leiomyoma of uterus	0.000	0.990	0.010
K60.2 Anal fissure, unspecified	0.000	0.990	0.010
K51.5 Mucosal proctocolitis	0.000	0.990	0.010
D25.2 Subserosal leiomyoma of uterus	0.000	0.991	0.009
N94.6 Dysmenorrhoea, unspecified	0.009	0.991	0.000
K50-K52 Noninfective enteritis and colitis	0.000	0.992	0.008
K60 Fissure and fistula of anal and rectal regions	0.000	0.992	0.008
I44 Atrioventricular and left bundle-branch block	0.000	0.992	0.008
K50 Crohn's disease [regional enteritis]	0.000	0.993	0.007
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.993	0.007
Z02.8 Other examinations for administrative purposes	0.007	0.993	0.000
K60.1 Chronic anal fissure	0.000	0.993	0.007
K60.3 Anal fistula	0.000	0.993	0.007
R59.0 Localised enlarged lymph nodes	0.000	0.993	0.007
K60.0 Acute anal fissure	0.000	0.993	0.007
K50.1 Crohn's disease of large intestine	0.000	0.994	0.006
K50.9 Crohn's disease, unspecified	0.000	0.994	0.006
K60.5 Anorectal fistula	0.000	0.994	0.006
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.994	0.006
I69 Sequelae of cerebrovascular disease	0.000	0.994	0.006
I44.0 Atrioventricular block, first degree	0.000	0.994	0.006
K50.0 Crohn's disease of small intestine	0.000	0.994	0.006
C67.9 Bladder, unspecified	0.000	0.994	0.006
I44.6 Other and unspecified fascicular block	0.000	0.994	0.006
I44.5 Left posterior fascicular block	0.000	0.994	0.006
I44.4 Left anterior fascicular block	0.000	0.994	0.006
Z80.3 Family history of malignant neoplasm of breast	0.006	0.994	0.000
K60.4 Rectal fistula	0.000	0.994	0.005
I44.3 Other and unspecified atrioventricular block	0.000	0.994	0.005
I44.1 Atrioventricular block, second degree	0.000	0.994	0.005
K50.8 Other Crohn's disease	0.000	0.995	0.005
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.995	0.005
I69.3 Sequelae of cerebral infarction	0.000	0.995	0.005
D69 Purpura and other haemorrhagic conditions	0.000	0.995	0.005
D69.6 Thrombocytopenia, unspecified	0.000	0.995	0.005
I44.2 Atrioventricular block, complete	0.000	0.995	0.005
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.995	0.005
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.005	0.995	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.995	0.005
M31.3 Wegener's granulomatosis	0.005	0.995	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.995	0.004
M31.6 Other giant cell arteritis	0.005	0.995	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.996	0.004
R94.4 Abnormal results of kidney function studies	0.004	0.996	0.000
M31 Other necrotising vasculopathies	0.004	0.996	0.000
D69.5 Secondary thrombocytopenia	0.000	0.996	0.004
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.996	0.004
D69.9 Haemorrhagic condition, unspecified	0.000	0.996	0.004
D69.8 Other specified haemorrhagic conditions	0.000	0.996	0.004
D69.4 Other primary thrombocytopenia	0.000	0.996	0.004
D69.2 Other nonthrombocytopenic purpura	0.000	0.996	0.004
D69.1 Qualitative platelet defects	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
K01.1 Impacted teeth	0.000	0.996	0.004
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.996	0.004
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.996	0.004
T42.3 Barbiturates	0.000	0.996	0.004
T42.2 Succinimides and oxazolidinediones	0.000	0.996	0.004
D69.0 Allergic purpura	0.000	0.996	0.003
K62.6 Ulcer of anus and rectum	0.000	0.996	0.004
T43.2 Other and unspecified antidepressants	0.000	0.996	0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.003
T42.1 Iminostilbenes	0.000	0.996	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.003
D21.2 Connective and other soft tissue of lower limb, including hip	0.003	0.997	0.000
D21 Other benign neoplasms of connective and other soft tissue	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
K52 Other non-infective gastro-enteritis and colitis	0.001	0.997	0.003
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.000	0.997	0.003
K76.8 Other specified diseases of liver	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
M31.9 Necrotising vasculopathy, unspecified	0.003	0.997	0.000
M31.8 Other specified necrotising vasculopathies	0.003	0.997	0.000
M31.7 Microscopic polyangiitis	0.003	0.997	0.000
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.003	0.997	0.000
M31.4 Aortic arch syndrome [Takayasu]	0.003	0.997	0.000
M31.2 Lethal midline granuloma	0.003	0.997	0.000
M31.1 Thrombotic microangiopathy	0.003	0.997	0.000
M31.0 Hypersensitivity angiitis	0.003	0.997	0.000
Z02 Examination and encounter for administrative purposes	0.003	0.997	0.000
D21.0 Connective and other soft tissue of head, face and neck	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
K04.8 Radicular cyst	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
Z50.5 Speech therapy	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
T39.1 4-Aminophenol derivatives	0.000	0.997	0.003
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.003
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
T42.4 Benzodiazepines	0.000	0.997	0.003
Z50.1 Other physical therapy	0.000	0.997	0.003
K62 Other diseases of anus and rectum	0.000	0.997	0.003
T88.7 Unspecified adverse effect of drug or medicament	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.003
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.997	0.003
Z50 Care involving use of rehabilitation procedures	0.000	0.997	0.003
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
D21.9 Connective and other soft tissue, unspecified	0.003	0.997	0.000
D21.6 Connective and other soft tissue of trunk, unspecified	0.003	0.997	0.000
D21.5 Connective and other soft tissue of pelvis	0.003	0.997	0.000
D21.4 Connective and other soft tissue of abdomen	0.003	0.997	0.000
D21.3 Connective and other soft tissue of thorax	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
K01 Embedded and impacted teeth	0.000	0.997	0.003
K52.9 Non-infective gastro-enteritis and colitis, unspecified	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
T51.0 Ethanol	0.000	0.997	0.003
K52.2 Allergic and dietetic gastro-enteritis and colitis	0.001	0.997	0.002
R04.2 Haemoptysis	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.003	0.997	0.000
M54.59 Low back pain (Site unspecified)	0.000	0.997	0.003
T39.0 Salicylates	0.000	0.997	0.002
A08.4 Viral intestinal infection, unspecified	0.000	0.997	0.003
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.002
K05.3 Chronic periodontitis	0.000	0.997	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.002
T46.7 Peripheral vasodilators	0.000	0.997	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.002
Z02.9 Examination for administrative purposes, unspecified	0.002	0.997	0.000
Z02.7 Issue of medical certificate	0.002	0.997	0.000
Z02.6 Examination for insurance purposes	0.002	0.997	0.000
Z02.5 Examination for participation in sport	0.002	0.997	0.000
Z02.4 Examination for driving licence	0.002	0.997	0.000
Z02.3 Examination for recruitment to armed forces	0.002	0.997	0.000
Z02.2 Examination for admission to residential institution	0.002	0.997	0.000
Z02.1 Pre-employment examination	0.002	0.997	0.000
Z02.0 Examination for admission to educational institution	0.002	0.997	0.000
K62.2 Anal prolapse	0.000	0.997	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.002
T36.8 Other systemic antibiotics	0.000	0.997	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.002
T36.6 Rifamycins	0.000	0.997	0.002
T36.5 Aminoglycosides	0.000	0.997	0.002
T36.4 Tetracyclines	0.000	0.997	0.002
T36.3 Macrolides	0.000	0.997	0.002
T36.2 Chloramphenicol group	0.000	0.997	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.002
T36.0 Penicillins	0.000	0.997	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.002
T37.5 Antiviral drugs	0.000	0.997	0.002
T37.4 Anthelminthics	0.000	0.997	0.002
T37.3 Other antiprotozoal drugs	0.000	0.997	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.002
T37.1 Antimycobacterial drugs	0.000	0.997	0.002
T37.0 Sulphonamides	0.000	0.997	0.002
T41.5 Therapeutic gases	0.000	0.997	0.002
T41.4 Anaesthetic, unspecified	0.000	0.997	0.002
T41.3 Local anaesthetics	0.000	0.997	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.002
T41.1 Intravenous anaesthetics	0.000	0.997	0.002
T41.0 Inhaled anaesthetics	0.000	0.997	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.002
T47.7 Emetics	0.000	0.997	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.002
T47.5 Digestants	0.000	0.997	0.002
T47.4 Other laxatives	0.000	0.997	0.002
T47.3 Saline and osmotic laxatives	0.000	0.997	0.002
T47.2 Stimulant laxatives	0.000	0.997	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.002
T48.5 Anti-common-cold drugs	0.000	0.997	0.002
T48.4 Expectorants	0.000	0.997	0.002
T48.3 Antitussives	0.000	0.997	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.002
T48.0 Oxytocic drugs	0.000	0.997	0.002
T49.9 Topical agent, unspecified	0.000	0.997	0.002
T49.8 Other topical agents	0.000	0.997	0.002
T49.7 Dental drugs, topically applied	0.000	0.997	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.002
T49.2 Local astringents and local detergents	0.000	0.997	0.002
T49.1 Antipruritics	0.000	0.997	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.000	0.998	0.002
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.000	0.998	0.002
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.998	0.002
M34.9 Systemic sclerosis, unspecified	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
J18.9 Pneumonia, unspecified	0.000	0.998	0.002
Z50.0 Cardiac rehabilitation	0.000	0.998	0.002
K04 Diseases of pulp and periapical tissues	0.000	0.998	0.002
D68.8 Other specified coagulation defects	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
R59 Enlarged lymph nodes	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
K52.0 Gastro-enteritis and colitis due to radiation	0.001	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
C67 Malignant neoplasm of bladder	0.000	0.998	0.002
D68 Other coagulation defects	0.000	0.998	0.002
Z50.6 Orthoptic training	0.000	0.998	0.002
Z50.3 Drug rehabilitation	0.000	0.998	0.002
K04.4 Acute apical periodontitis of pulpal origin	0.000	0.998	0.002
K01.0 Embedded teeth	0.000	0.998	0.002
K52.3 Indeterminate colitis	0.001	0.998	0.001
K62.0 Anal polyp	0.000	0.998	0.002
T88.4 Failed or difficult intubation	0.000	0.998	0.002
C67.1 Dome of bladder	0.000	0.998	0.002
R94 Abnormal results of function studies	0.002	0.998	0.000
T88 Other complications of surgical and medical care, not elsewhere classified	0.000	0.998	0.002
K52.1 Toxic gastro-enteritis and colitis	0.001	0.998	0.002
K62.9 Disease of anus and rectum, unspecified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T78.1 Other adverse food reactions, not elsewhere classified	0.002	0.998	0.000
T84.0 Mechanical complication of internal joint prosthesis	0.002	0.998	0.000
K72.9 Hepatic failure, unspecified	0.000	0.998	0.002
R59.1 Generalised enlarged lymph nodes	0.000	0.998	0.002
T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts	0.000	0.998	0.002
R94.3 Abnormal results of cardiovascular function studies	0.002	0.998	0.000
D68.5 Primary Thrombophilia	0.000	0.998	0.002
M86.9 Osteomyelitis, unspecified	0.002	0.998	0.000
K05 Gingivitis and periodontal diseases	0.000	0.998	0.002
D68.0 Von Willebrand's disease	0.000	0.998	0.002
D67 Hereditary factor IX deficiency	0.000	0.998	0.002
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.000	0.998	0.002
K04.3 Abnormal hard tissue formation in pulp	0.000	0.998	0.002
K04.2 Pulp degeneration	0.000	0.998	0.002
K04.1 Necrosis of pulp	0.000	0.998	0.002
K04.0 Pulpitis	0.000	0.998	0.002
T78.0 Anaphylactic shock due to adverse food reaction	0.002	0.998	0.000
C67.3 Anterior wall of bladder	0.000	0.998	0.002
D68.6 Other Thrombophilia	0.000	0.998	0.002
K70.9 Alcoholic liver disease, unspecified	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.000	0.998	0.002
T40.5 Cocaine	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
T40.1 Heroin	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
D39.1 Ovary	0.002	0.998	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.002	0.998	0.000
D68.4 Acquired coagulation factor deficiency	0.000	0.998	0.002
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.000	0.998	0.002
D68.1 Hereditary factor XI deficiency	0.000	0.998	0.002
T88.8 Other specified complications of surgical and medical care, not elsewhere classified	0.000	0.998	0.002
T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered	0.000	0.998	0.002
Z50.2 Alcohol rehabilitation	0.000	0.998	0.002
C67.8 Overlapping lesion of bladder	0.000	0.998	0.002
C67.7 Urachus	0.000	0.998	0.002
Z50.8 Care involving use of rehabilitation procedures	0.002	0.998	0.000
C67.5 Bladder neck	0.000	0.998	0.002
D68.9 Coagulation defect, unspecified	0.000	0.998	0.002
K52.8 Other specified non-infective gastro-enteritis and colitis	0.001	0.998	0.001
T88.5 Other complications of anaesthesia	0.000	0.998	0.002
M34 Systemic sclerosis	0.002	0.998	0.000
O04.4 Incomplete, without complication	0.002	0.998	0.000
K07 Dentofacial anomalies [including malocclusion]	0.000	0.998	0.002
R29.6 Tendency to fall, not elsewhere classified	0.002	0.998	0.000
R94.8 Abnormal results of function studies of other organs and systems	0.002	0.998	0.000
R94.7 Abnormal results of other endocrine function studies	0.002	0.998	0.000
R94.6 Abnormal results of thyroid function studies	0.002	0.998	0.000
R94.2 Abnormal results of pulmonary function studies	0.002	0.998	0.000
R94.1 Abnormal results of function studies of peripheral nervous system and special senses	0.002	0.998	0.000
R94.0 Abnormal results of function studies of central nervous system	0.002	0.998	0.000
T88.9 Complication of surgical and medical care, unspecified	0.000	0.998	0.002
T88.3 Malignant hyperthermia due to anaesthesis	0.000	0.998	0.002
T88.2 Shock due to anaesthesia	0.000	0.998	0.002
T88.1 Other complications following immunisation, not elsewhere classified	0.000	0.998	0.002
T88.0 Infection following immunisation	0.000	0.998	0.002
K00-K14 Diseases of oral cavity, salivary glands and jaws	0.000	0.998	0.002
K07.6 Temporomandibular joint disorders	0.000	0.998	0.002
I78.1 Naevus, nonneoplastic	0.002	0.998	0.000
T78 Adverse effects, not elsewhere classified	0.002	0.998	0.000
C67.6 Ureteric orifice	0.000	0.998	0.002
C67.0 Trigone of bladder	0.000	0.998	0.002
K11.8 Other diseases of salivary glands	0.000	0.998	0.002
K70.4 Alcoholic hepatic failure	0.000	0.998	0.002
M86.99 Osteomyelitis, unspecified (Site unspecified)	0.002	0.998	0.000
M86.98 Osteomyelitis, unspecified (Other)	0.002	0.998	0.000
M86.96 Osteomyelitis, unspecified (Lower leg)	0.002	0.998	0.000
M86.95 Osteomyelitis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M86.94 Osteomyelitis, unspecified (Hand)	0.002	0.998	0.000
M86.93 Osteomyelitis, unspecified (Forearm)	0.002	0.998	0.000
M86.92 Osteomyelitis, unspecified (Upper arm)	0.002	0.998	0.000
M86.91 Osteomyelitis, unspecified (Shoulder region)	0.002	0.998	0.000
M86.90 Osteomyelitis, unspecified (Multiple sites)	0.002	0.998	0.000
K05.2 Acute periodontitis	0.000	0.998	0.002
K05.5 Other periodontal diseases	0.000	0.998	0.002
K05.4 Periodontosis	0.000	0.998	0.002
K05.0 Acute gingivitis	0.000	0.998	0.002
K07.3 Anomalies of tooth position	0.000	0.998	0.002
M22.4 Chondromalacia patellae	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.002
K00 Disorders of tooth development and eruption	0.000	0.998	0.002
K72 Hepatic failure, not elsewhere classified	0.000	0.998	0.002
M13.94 Arthritis, unspecified (Hand)	0.002	0.998	0.000
K00.6 Disturbances in tooth eruption	0.000	0.998	0.002
K05.6 Periodontal disease, unspecified	0.000	0.998	0.002
D66 Hereditary factor VIII deficiency	0.000	0.998	0.001
K62.7 Radiation proctitis	0.000	0.998	0.002
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.002	0.998	0.000
M34.1 CR(E)ST syndrome	0.002	0.998	0.000
K11 Diseases of salivary glands	0.000	0.998	0.002
K04.6 Periapical abscess with sinus	0.000	0.998	0.002
M34.8 Other forms of systemic sclerosis	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.002	0.998	0.000
D00-D09 In situ neoplasms	0.002	0.998	0.000
C67.4 Posterior wall of bladder	0.000	0.998	0.002
K62.3 Rectal prolapse	0.000	0.998	0.002
M34.2 Systemic sclerosis induced by drugs and chemicals	0.002	0.998	0.000
M34.0 Progressive systemic sclerosis	0.002	0.998	0.000
K70 Alcoholic liver disease	0.000	0.998	0.002
C67.2 Lateral wall of bladder	0.000	0.998	0.002
K04.5 Chronic apical periodontitis	0.000	0.998	0.002
K14.8 Other diseases of tongue	0.000	0.998	0.002
M86 Osteomyelitis	0.002	0.998	0.000
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.002	0.998	0.000
K05.1 Chronic gingivitis	0.000	0.998	0.001
K07.9 Dentofacial anomaly, unspecified	0.000	0.998	0.001
K07.8 Other dentofacial anomalies	0.000	0.998	0.001
K07.5 Dentofacial functional abnormalities	0.000	0.998	0.001
K07.2 Anomalies of dental arch relationship	0.000	0.998	0.001
K07.0 Major anomalies of jaw size	0.000	0.998	0.001
K07.1 Anomalies of jaw-cranial base relationship	0.000	0.998	0.001
T78.2 Anaphylactic shock, unspecified	0.002	0.998	0.000
J01.9 Acute sinusitis, unspecified	0.002	0.998	0.000
K14 Diseases of tongue	0.000	0.998	0.002
K03 Other diseases of hard tissues of teeth	0.000	0.998	0.001
D73.0 Hyposplenism	0.000	0.998	0.002
K07.4 Malocclusion, unspecified	0.000	0.998	0.001
K11.9 Disease of salivary gland, unspecified	0.000	0.998	0.002
T78.9 Adverse effect, unspecified	0.001	0.998	0.000
T78.8 Other adverse effects, not elsewhere classified	0.001	0.998	0.000
T51 Toxic effect of alcohol	0.000	0.998	0.002
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
I50.9 Heart failure, unspecified	0.000	0.998	0.002
K11.5 Sialolithiasis	0.000	0.998	0.002
M86.6 Other chronic osteomyelitis	0.001	0.998	0.000
N86 Erosion and ectropion of cervix uteri	0.000	0.998	0.002
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.000	0.998	0.001
K05.22 Aggressive periodontitis, generalized	0.000	0.998	0.001
K00.9 Disorder of tooth development, unspecified	0.000	0.998	0.001
K00.8 Other disorders of tooth development	0.000	0.998	0.001
K00.7 Teething syndrome	0.000	0.998	0.001
K00.5 Hereditary disturbances in tooth structure, not elsewhere classified	0.000	0.998	0.001
K00.4 Disturbances in tooth formation	0.000	0.998	0.001
K00.3 Mottled teeth	0.000	0.998	0.001
K00.2 Abnormalities of size and form of teeth	0.000	0.998	0.001
K00.1 Supernumerary teeth	0.000	0.998	0.001
K00.0 Anodontia	0.000	0.998	0.001
K72.0 Acute and subacute hepatic failure	0.000	0.998	0.001
N92.1 Excessive and frequent menstruation with irregular cycle	0.000	0.998	0.002
O00.1 Tubal pregnancy	0.001	0.998	0.000
K76 Other diseases of liver	0.000	0.998	0.002
M22 Disorders of patella	0.002	0.998	0.000
M00.91 Pyogenic arthritis, unspecified (Shoulder region)	0.001	0.998	0.000
K11.6 Mucocele of salivary gland	0.000	0.998	0.001
K72.1 Chronic hepatic failure	0.000	0.998	0.001
K91.4 Colostomy and enterostomy malfunction	0.000	0.998	0.002
M86.67 Other chronic osteomyelitis (Ankle and foot)	0.001	0.998	0.000
N80.0 Endometriosis of uterus	0.000	0.998	0.002
K10 Other diseases of jaws	0.000	0.998	0.001
K11.7 Disturbances of salivary secretion	0.000	0.998	0.001
K11.4 Fistula of salivary gland	0.000	0.998	0.001
K11.3 Abscess of salivary gland	0.000	0.998	0.001
K11.0 Atrophy of salivary gland	0.000	0.998	0.001
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.001	0.998	0.000
R94.5 Abnormal results of liver function studies	0.001	0.999	0.000
T40.2 Other opioids	0.000	0.999	0.001
Y45.1 Salicylates	0.000	0.999	0.001
D02 Carcinoma in situ of middle ear and respiratory system	0.001	0.999	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.001	0.999	0.000
M24.26 Disorder of ligament (Lower leg)	0.001	0.999	0.000
K04.7 Periapical abscess without sinus	0.000	0.999	0.001
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.999	0.001
K70.1 Alcoholic hepatitis	0.000	0.999	0.001
M35.3 Polymyalgia rheumatica	0.001	0.999	0.000
M35.2 Behcet's disease	0.001	0.999	0.000
M86.8 Other osteomyelitis	0.001	0.999	0.000
M86.5 Other chronic haematogenous osteomyelitis	0.001	0.999	0.000
M86.4 Chronic osteomyelitis with draining sinus	0.001	0.999	0.000
M86.3 Chronic multifocal osteomyelitis	0.001	0.999	0.000
M86.2 Subacute osteomyelitis	0.001	0.999	0.000
M86.1 Other acute osteomyelitis	0.001	0.999	0.000
M86.0 Acute haematogenous osteomyelitis	0.001	0.999	0.000
M89.9 Disorder of bone, unspecified	0.001	0.999	0.000
M00.96 Pyogenic arthritis, unspecified (Lower leg)	0.001	0.999	0.000
M24.02 Loose body in joint (Upper arm)	0.001	0.999	0.000
J30.1 Allergic rhinitis due to pollen	0.000	0.999	0.001
K62.4 Stenosis of anus and rectum	0.000	0.999	0.001
K62.1 Rectal polyp	0.000	0.999	0.001
M22.3 Other derangements of patella	0.001	0.999	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.001	0.999	0.000
D04.7 Skin of lower limb, including hip	0.000	0.999	0.001
E53.8 Deficiency of other specified B group vitamins	0.001	0.999	0.000
K03.9 Disease of hard tissues of teeth, unspecified	0.000	0.999	0.001
K03.8 Other specified diseases of hard tissues of teeth	0.000	0.999	0.001
K03.7 Posteruptive colour changes of dental hard tissues	0.000	0.999	0.001
K03.6 Deposits [accretions] on teeth	0.000	0.999	0.001
K03.5 Ankylosis of teeth	0.000	0.999	0.001
K03.4 Hypercementosis	0.000	0.999	0.001
K03.3 Pathological resorption of teeth	0.000	0.999	0.001
K03.2 Erosion of teeth	0.000	0.999	0.001
K03.1 Abrasion of teeth	0.000	0.999	0.001
K03.0 Excessive attrition of teeth	0.000	0.999	0.001
K14.6 Glossodynia	0.000	0.999	0.001
K14.5 Plicated tongue	0.000	0.999	0.001
K14.4 Atrophy of tongue papillae	0.000	0.999	0.001
K14.3 Hypertrophy of tongue papillae	0.000	0.999	0.001
K14.2 Median rhomboid glossitis	0.000	0.999	0.001
K14.1 Geographic tongue	0.000	0.999	0.001
T51.8 Other alcohols	0.000	0.999	0.001
T51.3 Fusel oil	0.000	0.999	0.001
T51.2 2-Propanol	0.000	0.999	0.001
T51.1 Methanol	0.000	0.999	0.001
O04 Medical abortion	0.001	0.999	0.000
M86.69 Other chronic osteomyelitis (Site unspecified)	0.001	0.999	0.000
M86.68 Other chronic osteomyelitis (Other)	0.001	0.999	0.000
M86.66 Other chronic osteomyelitis (Lower leg)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations